Amazon’s RxPass Doesn’t Yet Really Compete With Mark Cuban’s Cost Plus Drug Company
Forbes· 5 日前Amazon is adding RxPass to its pharmacy footprint. By paying a monthly flat fee of $5 an Amazon ...
Bristol Myers' profit beats on better-than-feared Revlimid sales
Reuters· 5 日前Bristol Myers Squibb Co (BMY.N) on Thursday reported quarterly earnings that beat analysts' ...
WWE NXT Vengeance Day 2023 Results: Winners And Grades As Bron Breakker Retains
Forbes· 4 日前WWE NXT advertised Grayson Waller challenging Bron Breakker for the WWE NXT Championship inside ...
Pesticide antitrust cases consolidated in North Carolina federal court
Reuters· 7 小時前Ten lawsuits alleging two major pesticide makers engaged in a scheme to artificially inflate farmers' costs prices have ...
Google winds down feature that put playable podcasts directly in search results
TechCrunch· 7 小時前Google confirmed it’s putting an end to a feature that allowed users to access playable ...
Bristol Myers Q4 earnings sag on lower Revlimid sales
Reuters· 6 日前Drugmaker Bristol Myers Squibb said on Thursday its fourth quarter sales and earnings had fallen, hurt by lower sales of ...
Novartis says operating profit to grow again ahead of Sandoz spin-off
Reuters· 7 日前Novartis (NOVN.S) on Wednesday predicted that core operating income would grow in a "mid ...
5 Tips To Pass The Resume 30-Second Test
Forbes· 6 日前You can spend hours crafting your resume and conducting your job search, but today’s labor ...
Europe turns up heat under chemicals industry to clean up its climate act
Reuters· 12 小時前Certain images tend to dominate when thinking about the worst sectors of the modern economy for ...
India's Zydus Lifesciences beats Q3 profit view on strong India, U.S. sales
Reuters· 5 日前Indian generic drugmaker Zydus Lifesciences Ltd reported a bigger-than-expected 24.5% rise in ...
